Imaging Probe Development Center (IPDC)

About the Director

Dr. Gary L. Griffiths is the first Director of the Imaging Probe Development Center (IPDC) at the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), and brings to the position over 25 years experience in synthetic chemistry and radiochemistry, much of it related to biologic imaging and disease-specific targeting. Dr. Griffiths received his B.Sc., with Honors, in chemistry, from the University of Liverpool, England, in 1975, and earned his PH. D. in organic chemistry from the University of Nottingham, England, in 1980. In 1985, Dr. Griffiths went to work for a biopharmaceutical company, Immunomedics, Inc. as a Senior Scientist. He later served as Assistant Director of Chemistry and Immunochemistry and then as Director of Chemistry and Radioimmunology. From 1994 on, he was the Executive Director of Chemistry Research. While there, his research was mainly related to targeted approaches to cancer diagnosis and therapy, designing, preparing and testing numerous monoclonal antibody conjugates of drugs, polymers, enzymes, toxins, and radionuclides, and further developing agents for human clinical trials. Dr. Griffiths has published over 70 full articles in quality peer-reviewed journals, has over 150 abstracts and presentations, and has over 40 issued United States Patents, with a similar number of foreign counterparts, and multiple applications currently undergoing prosecution. He has spent most of his career working on the application of chemistry to biological systems within interdisciplinary environments.

Up to Top